Navigation Links
Environmental chemical blocks cell function
Date:12/6/2012

Bisphenol A, a substance found in many synthetic products, is considered to be harmful, particularly, for fetuses and babies. Researchers from the University of Bonn have now shown in experiments on cells from human and mouse tissue that this environmental chemical blocks calcium channels in cell membranes. Similar effects are elicited by drugs used to treat high blood pressure and cardiac arrhythmia. The results are now presented in the journal "Molecular Pharmacology."

The industrial chemical bisphenol A (BPA) is worldwide extensively utilized for manufacturing polycarbonates and synthetic resins. "This substance has been shown to affect the hormonal system and may have negative effects on the function of enzymes and carrier proteins," reports Prof. Dr. Dieter Swandulla from the Institute of Physiology II at the University of Bonn. BPA is associated with heart disease, diabetes, obesity, cancer, and neurological dysfunction. "It seems that fetuses and newborns are particularly sensitive to BPA," adds the physiologist. Due to its unpredictable effects, the EU Commission banned the use of BPA in baby bottles in 2011 as a precaution.

Bisphenol A blocks multiple essential calcium channels

The team of researchers around Prof. Swandulla now reports that BPA reversibly blocks calcium channels essential for cell function in mouse and human cells. Calcium ions flowing through these pore-like so-called channel proteins into living cells, control e.g. the contraction of heart muscle cells, the activity of enzymes, and the communication of nerve cells with each other. "Drugs such as those used to treat high blood pressure and cardiac arrhythmia on the one hand, and neurotoxins, such as heavy metals, on the other hand act on exactly the same calcium channels," explains the physiologist from the University of Bonn. "This indicates that BPA can indeed have adverse effects on human health." Since BPA binds to the calcium channels reversibly, there is at least the possibility of the chemical being eliminated from the body.

Bisphenol A and its derivatives are ubiquitous

Nowadays BPA and its related substances can be detected almost everywhere in the environment. Effective doses are found in CD's, paper money, thermal paper, food cans, dental fillings and flame retardants, even in the breathing air and in house dust. Humans are meanwhile chronically exposed to these compounds. "This is why it would be desirable to completely stop the production of BPA," says Prof. Swandulla. "Due to the high-volume production and its widespread occurrence, it would, however, take a very long time to remove this chemical from the environment and the human organism." Consequently, alternatives to BPA should be utilized which are harmless to humans and other organisms.


'/>"/>
Contact: Prof. Dr. Dieter Swandulla
dieter.swandulla@ukb.uni-bonn.de
40-228-736-0100
University of Bonn
Source:Eurekalert

Related biology news :

1. Forest killer plant study explores rapid environmental change factors
2. Environmental activist David Suzuki is fifth recipient of CWRU’s Inamori Ethics Prize
3. Concern about plans to close unique Canadian environmental project
4. Study shows hope of greater global food output, less environmental impact of agriculture
5. 2012 Reed Elsevier Environmental Challenge winners announced
6. Environmental groups should pool efforts to reach the public
7. New DataONE portal streamlines access to environmental data
8. University of Tennessee professor wins worlds top prize for ecology, environmental science
9. Environmental concerns increasing infectious disease in amphibians, other animals
10. UC Santa Barbara researchers play key role in UN Environmental Assessment
11. Scientists warn Brazils environmental leadership at risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: